Paul E. Van Schil
Antwerpen, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 247 publications
Bridging evidence and practice: international multidisciplinary consensus on non-metastatic NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: May 26, 2026
The role of tumor dimension among the different thymic tumor histologies: A European Society of Thoracic Surgeons thymic database analysis.
Journal: Surgery
Published: May 23, 2026
Prognostic implication of malignant pleural metastases in stage M1a non-small cell lung cancer in a real-world Dutch cohort receiving chemotherapy and/or immunotherapy.
Journal: The European respiratory journal
Published: March 16, 2026
HER2 expression and HER2 gene amplification in thymic epithelial tumors: a narrative review.
Journal: Mediastinum (Hong Kong, China)
Published: October 27, 2025
Corrigendum to 'Neoadjuvant Chemoimmunotherapy Complicates Subsequent Surgical Resection and Adjuvant Immunotherapy Is Preferable From the Surgical Standpoint' [Journal of Thoracic Oncology Volume 19 Issue 6 (2024) 858-861].
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 01, 2025
Bridging the Gap Between Radiology and Microscopy Using microCT: Implications for Neoplastic and Non-neoplastic Lung Disease.
Journal: Journal of thoracic imaging
Published: August 23, 2025
Lung Ischemia-Reperfusion Injury in Lung Transplant Surgery: Where Do We Stand?
Journal: Antioxidants (Basel, Switzerland)
Published: August 21, 2025
Differentiating benign and malignant solitary pulmonary nodules through exhaled breath analysis.
Journal: ERJ open research
Published: June 20, 2025
ETOP 25-23 ADOPT-lung: An international, multicentre, open-label randomised phase III trial to evaluate the benefit of adding adjuvant durvalumab after neoadjuvant chemotherapy plus durvalumab in patients with stage IIB-IIIB (N2) resectable NSCLC.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 18, 2025
Consensus definition of stage III non-small-cell lung cancer technical resectability to standardise inclusion criteria for clinical trials: a multisocietal EORTC-Lung Cancer Group collaboration.
Journal: The Lancet. Respiratory medicine
Published: May 02, 2025
Selective Pulmonary Artery Perfusion with Blood Flow Occlusion as a Treatment for Lung Malignancies.
Selective Pulmonary Artery Perfusion with Blood Flow Occlusion as a Treatment for Lung Malignancies.
Journal: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
Published: April 09, 2025
Last Updated: 09/26/2026